HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers.

Post-treatment monitoring is a crucial aspect of cancer care, focusing on the detection of recurrence or secondary cancers. Regular follow-up appointments, including imaging, blood tests, and physical exams, are designed to catch early signs of relapse. Patients are often monitored for a prolonged period, sometimes years, to ensure timely intervention in case of recurrence. Surveillance also helps to manage late side effects of treatment, including organ damage or secondary cancers caused by radiation or chemotherapy. Personalized surveillance plans, tailored to each patient’s specific cancer type, treatment history, and risk factors, improve the chances of detecting issues before they become life-threatening.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2027 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2027 - Michael Thompson

Michael Thompson

University of Toronto, Canada
Speaker at International Conference on Clinical & Translational Oncology 2027 - Alain Chapel

Alain Chapel

Institute Of Radiological Protection And Nuclear Safety, France
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Whatsapp